Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Kinnate Biopharma Inc. has filed 250 SEC EDGAR filings since 23 Dec 2019

SEC filing history

Showing 51-75 of 250 matching filings.

Per page
25
Current page
3
SC 13D/A File 005-91893

AMENDMENT NO. 5

Filing date
17 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91893

AMENDMENT NO. 4

Filing date
17 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91893

AMENDMENT NO. 4

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91893

AMENDMENT NO. 3

Filing date
14 Nov 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91893

SC 13G/A

Filing date
14 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2023
Reporting date
12 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jun 2023
Reporting date
01 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .